CaCO 3 ‐Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma

2021 ◽  
pp. 2100748
Author(s):  
Aimi Zhang ◽  
Zhisheng Xiao ◽  
Qiufang Liu ◽  
Panli Li ◽  
Fei Xu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Arterial Embolization ◽  
Embolization Treatment

scholarly journals Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Zhaonan Liu ◽  
Xingjie Li ◽  
Xuequn He ◽  
Yingchun Xu ◽  
Xi Wang
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Function ◽  
Arterial Embolization ◽  
Complete Response ◽  
Advanced Hepatocellular Carcinoma ◽  
Class B ◽  
Embolization Treatment ◽  
History Of ◽  
Pugh Class ◽  
Patient’S History

Abstract Background The majority of patients diagnosed with hepatocellular carcinoma (HCC) have advanced diseases and many are not eligible for curative therapies. Case presentation We report a rare case of HCC from a patient who had a complete response (CR) with the use of combination of Lenvatinib and Pembrolizumab. A 63-year-old man presented at the hospital with serious abdominal pain and was found to have a mass with heterogeneous enhancement and with hemorrhage in segment III of the liver after the examination of abdominal computerized tomography (CT) scan. The patient’s history of viral hepatitis B infection, liver cirrhosis and the ɑ-fetoprotein (AFP) level of 14,429.3 ng/ml supported the clinical diagnosis of HCC and laboratory results demonstrated liver function damage status (Child-Pugh class B, Score 8). The patient first received hepatic arterial embolization treatment on 28th November 2017. At this stage supportive care was recommended for poor liver function. In February 2018, combined immunotherapy of Pembrolizumab (2 mg/kg, q3w) and Lenvatinib (8 mg–4 mg, qd) were performed. Nine months following the treatment he had a CR and now, 22 months since the initial treatment, there is no clinical evidence of disease progression. The current overall survival is 22 months. Conclusions HCC is a potentially lethal malignant tumor and the combination of immunotherapy plus anti-angiogenic inhibitors shows promising outcome for advanced diseases.

Usefulness of pulsed doppler ultrasound in detection of angiographically evident recurrence of hepatocellular carcinoma after arterial embolization treatment

Hepatology ◽  
1991 ◽  
Vol 13 (3) ◽  
pp. 434-437 ◽  
Author(s):  
Satoshi Mochida ◽  
Shigeki Hayashi ◽  
Itsuro Ogata ◽  
Naohiko Masaki ◽  
Sumiko Nagoshi ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Doppler Ultrasound ◽  
Arterial Embolization ◽  
Pulsed Doppler ◽  
Pulsed Doppler Ultrasound ◽  
Embolization Treatment

Effect of Transcatheter Arterial Embolization according to Angiographic Findings in Hepatocellular Carcinoma

1994 ◽  
Vol 31 (5) ◽  
pp. 851
Author(s):  
Young Goo Kim ◽  
Kun Sang Kim ◽  
Jong Beum Lee ◽  
Hyung Jin Shim ◽  
Jong Ik Lee ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transcatheter Arterial Embolization ◽  
Arterial Embolization ◽  
Angiographic Findings

Enhancement of NK activity and LAK activity with biological response modifier after the trans-arterial embolization therapy in patients with hepatocellular carcinoma.

Kanzo ◽  
1989 ◽  
Vol 30 (5) ◽  
pp. 588-589
Author(s):  
Hiroyuki MATSUDA ◽  
Tetsuo TAKEHARA ◽  
Masahumi NAITO ◽  
Naoki HIRAMATSU ◽  
Hitoshi SAWAOKA ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Biological Response ◽  
Arterial Embolization ◽  
Biological Response Modifier ◽  
Nk Activity ◽  
Response Modifier ◽  
Embolization Therapy ◽  
Lak Activity

Palliative Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Embolization

1993 ◽  
Vol 34 (1) ◽  
pp. 26-29 ◽  
Author(s):  
S. Savastano ◽  
G. P. Feltrin ◽  
D. Neri ◽  
P. da Pian ◽  
M. Chiesura-Corona ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transcatheter Arterial Embolization ◽  
Palliative Treatment ◽  
Arterial Embolization

scholarly journals Correction: Isao N., et al. Transcatheter Arterial Embolization Treatment for Bleeding Visceral Artery Pseudoaneurysms in Patients with Pancreatitis or Following Pancreatic Surgery. Cancers 2020, 12, 2733

Cancers ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1312
Author(s):  
Isao Numoto ◽  
Masakatsu Tsurusaki ◽  
Teruyoshi Oda ◽  
Yukinobu Yagyu ◽  
Kazunari Ishii ◽  
...  
Keyword(s):  
Overall Survival ◽  
Transcatheter Arterial Embolization ◽  
Pancreatic Surgery ◽  
Arterial Embolization ◽  
Visceral Artery ◽  
Embolization Treatment ◽  
Published Paper

The authors are sorry to report that the overall survival reported in their recently published paper was incorrect [...]

Sign in / Sign up

Export Citation Format

Share Document